# WDH earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/WDH) · [Earnings tab](https://www.lopjlb.com/stock/WDH?tab=earnings) Updated: 2026-09-08T07:53:46 Quarters analyzed: 8 ## Cross-quarter narrative Across the eight earnings calls, Waterdrop moved from a quiet Q1 2024 with vague guidance to a high‑visibility narrative centered on rapid revenue expansion, AI‑driven insurance products, and robust capital returns. Q2 2024 introduced double‑digit profit growth, a $50 M share‑buyback and a special dividend, while highlighting AI/LLM use in insurance and healthcare. Subsequent quarters reinforced profit momentum, steady ~20% insurance margins, and a cascade of AI milestones, but also surfaced cost‑pressure and regulatory concerns. Q4 2024 marked the 12th consecutive profitable quarter, a doubled net profit, and the launch of AI agents that generate premium revenue. Early 2025 signaled continued insurance FYP growth but warned of higher H2 investment pressure on margins. FY 2025 delivered a 43% revenue surge and AI‑centric insurance growth, yet cost inflation strained margins. By Q1 2026 revenue rose 64.8% YoY, the company reaffirmed a 40% top‑line target, and AI patents and charitable initiatives expanded, while emphasizing cost‑control and ongoing dividends. Throughout, AI integration deepened, capital return programs intensified, and regulatory and competition risks persisted, shaping a trajectory of accelerating growth tempered by rising expenses and external uncertainties. ## Latest CallCard · Q1 Waterdrop posted 64.8% YoY revenue growth, strong insurance income, and reaffirmed a 40% top-line growth target while expanding AI patents and charitable programs. **Guidance:** maintained — Company reaffirmed its ~40% revenue growth target for 2026 and expects operating profit to remain broadly stable. **Tone:** mgmt 0.7 · Q&A pressure 0 · divergence 0.7 Management highlighted 40% revenue growth target, stable operating profit and increased marketing investment, indicating optimism. ### Demand visibility Visibility maintained The company has maintained gap‑proof visibility for 17 consecutive quarters, indicating stable demand outlook. ### Margins / costs Margins stable, cost control improving Q1 operating margin was 13.3%, up 2 percentage points QoQ despite a slight revenue dip, reflecting effective cost management. ### Capital allocation Ongoing dividends and share repurchases Completed a $10.8M cash dividend and repurchased $61.8M ADF, bringing total returns since IPO to about $170M. ### Milestones - **AI‑native transformation** [on_track]: Filed 75 LLM‑related patent applications and received two national invention patents. - **Digital clinical trial enrollment** [on_track]: More than 15,500 patients enrolled to date. - **Charity platform expansion** [on_track]: Partnered with 119 public charities and launched over 15,500 charity programs. - **Cloud Copilot beta** [new]: Started internal beta testing of cloud copilot on CRM and WECOM in late March. - **AI service agent usage** [on_track]: AI service agent now supports over 1 million service interactions per month. ### Fears / risks - **Traffic investment reliance**: Heavy reliance on increased traffic and AI spend could pressure margins if ROI does not improve. - **AI implementation risk**: Scaling AI tools such as Cloud Copilot and AI service agents may face integration challenges. - **Regulatory risk**: Forward‑looking statements are subject to risk factors outlined in the company’s filings. ### Key quotes > “we are targeting approximately 40% top-line growth with operating profit scale is expected to remain broadly stable” > “the operating margin of Q1 is 13.3%” — Wei Ran > “approximately 494 million people had cumulatively donated a total of $73.5 billion to 3.75 million patients through the Waterdrop Medical Profiling Platform” > “we completed our fifth cash dividend since our IPO, totaling approximately $10.8 million” > “we launched a dedicated customer complaint hotline make it easier for users to raise concerns” ## Quarter one-liners - **2026 Q1:** Waterdrop posted 64.8% YoY revenue growth, strong insurance income, and reaffirmed a 40% top-line growth target while expanding AI patents and charitable programs. - **2025 Q4:** Waterdrop reported FY2025 revenue of CNY 3.98 bn (+43.5% YoY) and net profit of CNY 570 m (+54.8% YoY), met guidance, declared a dividend and share repurchase, and highlighted AI‑driven insurance growth. - **2025 Q2:** — - **2025 Q1:** Waterdrop Q1 2025: revenue up 7% YoY to RMB 754M, net profit up 34% to RMB 108M; insurance FYP up 19% to RMB 2.09B; guidance for >20% annual revenue growth but higher H2 investment may pressure profit. - **2024 Q4:** Waterdrop Q4 2024: revenue $687M, full year $2.77B (+5.4% YoY), net profit doubled, 12th consecutive profitable quarter; third cash dividend $0.20/share, $104M buybacks; 2025 target 20% revenue growth; AI agents generating millions in premiums monthly. - **2024 Q3:** Waterdrop posted 160% YoY profit growth, steady 20% insurance margin, expanded AI platform and clinical trial enrollments, while repurchasing shares and boosting R&D. - **2024 Q2:** Waterdrop Q2 2024: revenue RMB676M, net profit up 300% YoY to RMB88.3M, insurance FYP RMB1.78B with >21% margin, new $50M buyback and $7.5M special dividend, AI/LLM expanding in insurance and healthcare. - **2024 Q1:** — ## Theme arcs - **Revenue growth** (improving): From modest guidance to 64% YoY growth and 43% FY2025 increase. - **Profitability** (improving): Net profit doubled in Q4 2024 and grew 55% YoY in FY2025. - **AI integration** (improving): Progressive rollout of AI agents, platforms, and patents across calls. - **Capital returns** (improving): Share buybacks and dividends expanded each quarter. - **Cost pressure** (deteriorating): Operating costs rose Q3 2024, cost inflation >100% YoY FY2025, later stabilizing. - **Regulatory risk** (new): First noted Q3 2024 and recurring thereafter. - **Market competition** (new): Identified as a risk in Q3 2024 and again in FY2025. - **Insurance demand** (improving): Short‑term insurance surged 44% YoY and FYP up 19% YoY Q1 2025. ## Guidance path 2024 Q1:vague → 2024 Q2:maintained → 2024 Q3:vague → 2024 Q4:vague → 2025 Q1:maintained → 2025 Q2:vague → 2025 Q4:maintained → 2026 Q1:maintained --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/WDH`